Table 1.
Characteristics of 113 osteosarcoma patients.
| Age at diagnosis in years, median (range) | 15.0 (5.6–43.0) |
|---|---|
| Sex, number of males (%) | 64 (56.6) |
| Self-reported ethnicity, number of Caucasians (%) | 113 (100) |
| Metastases present at diagnosis, number of patients (%) | 20 (17.7) |
| Treatment protocol, number of patients in EURAMOS-1 (%) | 113 (100) |
| EURAMOS-1 treatment arm, number of patients (%) | |
| MAP | 50 (44.2) |
| MAPie | 15 (13.3) |
| MAPifn | 12 (10.6) |
| Personalized | 4 (3.5) |
| Unknown | 32 (28.3) |
| MTX cumulative dose (12 g/m2 per course), number of patients | |
| 12–72 g/m² | 8 |
| 84–132 g/m² | 16 |
| 144 g/m² | 89 |
MAP, regimen of methotrexate, doxorubicin, cisplatin; MAPie, regimen of methotrexate, doxorubicin, cisplatin, ifosfamide, etoposide; MAPinf, regimen of methotrexate, doxorubicin, cisplatin, interferon-alfa.